DE602007010425D1 - Neue fsh-glykosilierungsvariante d3n - Google Patents

Neue fsh-glykosilierungsvariante d3n

Info

Publication number
DE602007010425D1
DE602007010425D1 DE602007010425T DE602007010425T DE602007010425D1 DE 602007010425 D1 DE602007010425 D1 DE 602007010425D1 DE 602007010425 T DE602007010425 T DE 602007010425T DE 602007010425 T DE602007010425 T DE 602007010425T DE 602007010425 D1 DE602007010425 D1 DE 602007010425D1
Authority
DE
Germany
Prior art keywords
glycosilation
version
fsh
new
new fsh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007010425T
Other languages
English (en)
Inventor
Marco Muda
Xuliang Jiang
Sean D Mckenna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Merck Serono SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono SA filed Critical Merck Serono SA
Publication of DE602007010425D1 publication Critical patent/DE602007010425D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602007010425T 2006-01-17 2007-01-16 Neue fsh-glykosilierungsvariante d3n Active DE602007010425D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75948606P 2006-01-17 2006-01-17
PCT/US2007/001004 WO2007084441A2 (en) 2006-01-17 2007-01-16 Novel fsh glycosylation variant d3n

Publications (1)

Publication Number Publication Date
DE602007010425D1 true DE602007010425D1 (de) 2010-12-23

Family

ID=38163618

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007010425T Active DE602007010425D1 (de) 2006-01-17 2007-01-16 Neue fsh-glykosilierungsvariante d3n

Country Status (22)

Country Link
US (1) US7956034B2 (de)
EP (1) EP1981908B1 (de)
JP (1) JP2009523445A (de)
KR (1) KR20080094697A (de)
CN (1) CN101370825B (de)
AR (1) AR059054A1 (de)
AT (1) ATE487738T1 (de)
AU (1) AU2007207697B2 (de)
BR (1) BRPI0706628A2 (de)
CA (1) CA2633844A1 (de)
CY (1) CY1110953T1 (de)
DE (1) DE602007010425D1 (de)
DK (1) DK1981908T3 (de)
EA (1) EA013974B1 (de)
HR (1) HRP20100610T1 (de)
IL (1) IL192547A (de)
PL (1) PL1981908T3 (de)
PT (1) PT1981908E (de)
RS (1) RS51792B (de)
SI (1) SI1981908T1 (de)
WO (1) WO2007084441A2 (de)
ZA (1) ZA200805194B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0520498B8 (pt) 2005-08-26 2021-05-25 Ares Trading Sa processo para fabricação de interferon beta humano recombinante glicosilado, e uso de um meio de cultura isento de soro
US8604175B2 (en) * 2005-12-09 2013-12-10 Ares Trading S.A. Method for purifying FSH or a FSH mutant
AU2006346358B2 (en) 2005-12-22 2012-01-19 Merck Serono Sa FSH mutants
US20100249381A1 (en) * 2007-10-22 2010-09-30 David Delvaille Method for Purifying FC-Fusion Proteins
JP2011500757A (ja) * 2007-10-22 2011-01-06 メルク セローノ ソシエテ アノニム Ｆｃ含有タンパク質の精製方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA985545B (en) * 1997-06-25 1999-04-01 Applied Research Systems Disulfide crosslinking glycoprotein hormone analogs and their preparation and use
WO2001058493A1 (en) * 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
CA2469724A1 (en) 2001-10-22 2004-06-17 Applied Research Systems Ars Holding N.V. Mutant glycoproteins
UA88879C2 (en) * 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
US8604175B2 (en) * 2005-12-09 2013-12-10 Ares Trading S.A. Method for purifying FSH or a FSH mutant

Also Published As

Publication number Publication date
CA2633844A1 (en) 2007-07-26
CN101370825B (zh) 2012-10-10
PT1981908E (pt) 2010-11-23
AU2007207697B2 (en) 2012-01-19
CN101370825A (zh) 2009-02-18
EP1981908A2 (de) 2008-10-22
EA200870177A1 (ru) 2009-02-27
JP2009523445A (ja) 2009-06-25
ATE487738T1 (de) 2010-11-15
PL1981908T3 (pl) 2011-04-29
BRPI0706628A2 (pt) 2011-04-05
DK1981908T3 (da) 2010-12-13
KR20080094697A (ko) 2008-10-23
WO2007084441A2 (en) 2007-07-26
IL192547A (en) 2012-04-30
AU2007207697A2 (en) 2008-07-31
WO2007084441A3 (en) 2007-09-07
US20080280832A1 (en) 2008-11-13
EA013974B1 (ru) 2010-08-30
ZA200805194B (en) 2009-10-28
EP1981908B1 (de) 2010-11-10
US7956034B2 (en) 2011-06-07
CY1110953T1 (el) 2015-06-11
AR059054A1 (es) 2008-03-12
RS51792B (en) 2011-12-31
AU2007207697A1 (en) 2007-07-26
SI1981908T1 (sl) 2011-01-31
HRP20100610T1 (hr) 2010-12-31
IL192547A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
DE602007003343D1 (de) Neue mikrobiozide
DE502007005527D1 (de) Dreh-/drücksteller
DK2046826T3 (da) Exendin-fusionsproteiner
DE602007007859D1 (de) Mikrowellenanordnung
DE602007012130D1 (de) Modifizierte flavin-adenin-dinucleotid-abhängige glucose-dehydrogenase
CR10841A (es) Imidazotriazinas imidazopirimidinas inhibidores de cinasa
FR2895920B1 (fr) Pipette multivolumes.
DE602006000836D1 (de) Leitungssteuerungsanordnung
DE602007013051D1 (de) Sprühvorrichtung
NO20080353L (no) Lampestyringssystem
DE602007010425D1 (de) Neue fsh-glykosilierungsvariante d3n
DK2275887T3 (da) Elektronisk styresystem
ITMO20050193A1 (it) Apparato illuminante
ATE524461T1 (de) Neue substituierte piperidylpropanthiole
DE102006032477A8 (de) Dunstabzugshaube
DE502007003958D1 (de) Leuchte
DE202005018500U1 (de) Doppel-Universaldimmer
DE602007001321D1 (de) Fernbedienung
DE602006010318D1 (de) Tonerverfahren
DK2081952T3 (da) Peptider
ATE518095T1 (de) Lichtsystem
BRPI0718609A2 (pt) Anticorpos modificadores de doença cancerosa.
ES1062478Y (es) Farola
CN300891766S (zh) 头灯(930)
ES1062858Y (es) Lampara